Protagonist Therapeutics, Inc. announced the appointment of Sarah O'Dowd as an independent director to the Protagonist Board of Directors. Ms. O'Dowd brings broad experience in management and corporate governance to Protagonist, including senior level oversight in the biopharmaceutical industry. In connection with the appointment, Chaitan Khosla, Ph.D., Professor of Chemistry and Engineering at Stanford University, is stepping down from his position on the board. Sarah O'Dowd has been a director of Ichor Holdings since May 2020. Ms. O'Dowd previously served as Senior Vice President, Chief Legal Officer and Secretary at the global technology firm Lam Research Corporation from October 2008 to March 2020. She also served as Lam Research's Vice President of Human Resources from 2009 to 2012. At Lam Research, Ms. O'Dowd led multiple initiatives relating to shareholder outreach on governance, ethics and compliance, IP strategy, foreign trade regulations and M&A transactions. Her experience includes the role of Vice President and General Counsel at FibroGen and a position on the board of directors of Corcept Therapeutics. Ms. O'Dowd currently serves on the board of directors of the non-profit organization, the Independent Institute, and previously served on the board of trustees of the non-profit organization, the Reason Foundation. Ms. O'Dowd began her career at the law firm Heller Ehrman, where she held responsibility for business strategy.